We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 41-60 of 10,000 results
  1. Remote Ischemic Post-conditioning Reduces Cognitive Impairment in Rats Following Subarachnoid Hemorrhage: Possible Involvement in STAT3/STAT5 Phosphorylation and Th17/Treg Cell Homeostasis

    The inflammatory response following subarachnoid hemorrhage (SAH) may lead to Early Brain Injury and subsequently contribute to poor prognosis such...

    Yajun Zhu, **aoguo Li, ... Zongduo Guo in Translational Stroke Research
    Article 15 February 2024
  2. Mitochondrial Dysfunction in Cardiotoxicity Induced by BCR-ABL1 Tyrosine Kinase Inhibitors -Underlying Mechanisms, Detection, Potential Therapies

    The advent of BCR-ABL tyrosine kinase inhibitors (TKIs) targeted therapy revolutionized the treatment of chronic myeloid leukemia (CML) patients....

    Sheng Sun, Jiqiu Qin, ... Shaoquan **ong in Cardiovascular Toxicology
    Article 21 July 2023
  3. DNA hypomethylator phenotype reprograms glutamatergic network in receptor tyrosine kinase gene-mutated glioblastoma

    DNA methylation is crucial for chromatin structure and gene expression and its aberrancies, including the global “hypomethylator phenotype”, are...

    Mio Harachi, Kenta Masui, ... Noriyuki Shibata in Acta Neuropathologica Communications
    Article Open access 13 March 2024
  4. Phosphorylation of β-catenin at Serine552 correlates with invasion and recurrence of non-functioning pituitary neuroendocrine tumours

    Non-functioning pituitary tumours (NF-PitNETs) are common intracranial benign neoplasms that can exhibit aggressive behaviour by invading...

    Ashutosh Rai, Soujanya D. Yelamanchi, ... Carles Gaston-Massuet in Acta Neuropathologica Communications
    Article Open access 16 September 2022
  5. Non-coding RNAs as potential therapeutic targets for receptor tyrosine kinase signaling in solid tumors: current status and future directions

    This review article presents an in-depth analysis of the current state of research on receptor tyrosine kinase regulatory non-coding RNAs (RTK-RNAs)...

    Aysan Moeinafshar, Mohammad Nouri, ... Mohammad-Reza Ghasemi in Cancer Cell International
    Article Open access 10 January 2024
  6. The role of protein tyrosine phosphatase 1B (PTP1B) in the pathogenesis of type 2 diabetes mellitus and its complications

    Insulin resistance, the most important characteristic of the type 2 diabetes mellitus (T2DM), is mostly caused by impairment in the insulin receptor...

    Maryam Teimouri, Hossein Hosseini, ... Reza Meshkani in Journal of Physiology and Biochemistry
    Article 06 January 2022
  7. Sushi domain-containing protein 4 binds to epithelial growth factor receptor and initiates autophagy in an EGFR phosphorylation independent manner

    Background

    Sushi domain-containing protein 4 (SUSD4) is a recently discovered protein with unknown cellular functions. We previously revealed that...

    Konstantinos S. Papadakos, Alexander Ekström, ... Anna M. Blom in Journal of Experimental & Clinical Cancer Research
    Article Open access 29 December 2022
  8. Modelling and targeting mitochondrial protein tyrosine phosphatase 1: a computational approach

    The present research scintillates on the homology modelling of rat mitochondrial protein tyrosine phosphatase 1 (PTPMT1) and targeting its activity...

    Venkataraghavan Ragunathan, K. Chithra, ... Meenambiga Setti Sudharsan in In Silico Pharmacology
    Article 17 January 2022
  9. Upregulation of Src Family Tyrosine Kinases in the Rat Striatum by Adenosine A2A Receptors

    Adenosine A 2A receptors are G olf -coupled receptors and are predominantly expressed in the striatum of mammalian brains. As a mostly postsynaptic...

    Li-Min Mao, Shannon Demehri, John Q. Wang in Journal of Molecular Neuroscience
    Article 18 January 2022
  10. Targeting mitochondrial oxidative phosphorylation: lessons, advantages, and opportunities

    Nicole D. Machado, Lisa C. Heather, ... Geoff S. Higgins in British Journal of Cancer
    Article Open access 10 August 2023
  11. Targeting the Receptor Tyrosine Kinase ROR1 by Small Molecules

    Receptor tyrosine kinases (RTKs) are frequently dysregulated in malignancies and important for the malignant characteristics of tumor cells. RTKs are...
    Mohammad Hojjat-Farsangi, Ali Moshfegh, ... Håkan Mellstedt in Pharmacology of the WNT Signaling System
    Chapter 2021
  12. Alzheimer risk gene product Pyk2 suppresses tau phosphorylation and phenotypic effects of tauopathy

    Background

    Genetic variation at the PTK2B locus encoding the protein Pyk2 influences Alzheimer’s disease risk. Neurons express Pyk2 and the protein...

    A. Harrison Brody, Sarah Helena Nies, ... Stephen M. Strittmatter in Molecular Neurodegeneration
    Article Open access 03 May 2022
  13. Altering phosphorylation in cancer through PP2A modifiers

    Protein phosphatase 2A (PP2A) is a serine/threonine phosphatase integral to the regulation of many cellular processes. Due to the deregulation of...

    Hannah Johnson, Satya Narayan, Arun K. Sharma in Cancer Cell International
    Article Open access 06 January 2024
  14. Tyrosine Kinases

    Reference work entry 2021
  15. Multiomics analysis identifies oxidative phosphorylation as a cancer vulnerability arising from myristoylation inhibition

    Background

    In humans, two ubiquitously expressed N-myristoyltransferases, NMT1 and NMT2, catalyze myristate transfer to proteins to facilitate...

    Erwan Beauchamp, Jay M. Gamma, ... Luc G. Berthiaume in Journal of Translational Medicine
    Article Open access 07 May 2024
  16. Tyrosine Kinases

    Living reference work entry 2021
  17. Host-derived growth factors drive ERK phosphorylation and MCL1 expression to promote osteosarcoma cell survival during metastatic lung colonization

    Purpose

    For patients with osteosarcoma, disease-related mortality most often results from lung metastasis—a phenomenon shared with many solid tumors....

    Camille A. McAloney, Rawan Makkawi, ... Ryan D. Roberts in Cellular Oncology
    Article Open access 07 September 2023
  18. Experimental evidence of tyrosine neurotoxicity: focus on mitochondrial dysfunction

    Tissue exposure to high levels of tyrosine, which is characteristic of an inborn error of metabolism named Tyrosinemia, is related to severe...

    Jade de Oliveira, Hémelin Resende Farias, Emilio Luiz Streck in Metabolic Brain Disease
    Article 02 July 2021
  19. Neuroprotective Effect of Curcumin on the Rat Model of Parkinson’s Disease Induced by Rotenone via Modulating Tyrosine Hydroxylase and Dopa Decarboxylase Expression Levels

    Abstract

    Parkinson’s disease is a progressive neurodegenerative disorder distinguished by degeneration of dopaminergic neuronal cells of the...

    Amina E. Essawy, Cecil A. Matta, ... Ahmed A. Soffar in Neurochemical Journal
    Article 30 August 2023
  20. Pirtobrutinib inhibits wild-type and mutant Bruton’s tyrosine kinase-mediated signaling in chronic lymphocytic leukemia

    Pirtobrutinib (LOXO-305), a reversible inhibitor of Bruton’s tyrosine kinase (BTK), was designed as an alternative strategy to treat...

    Burcu Aslan, Gorkem Kismali, ... Varsha Gandhi in Blood Cancer Journal
    Article Open access 20 May 2022
Did you find what you were looking for? Share feedback.